share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga Real-time News ·  May 6, 2022 09:07

 

Gainers

  • iRhythm Technologies (NASDAQ:IRTC) stock rose 21.6% to $143.58 during Friday's pre-market session. The company's market cap stands at $4.2 billion. As per the news, the Q1 earnings report came out yesterday.
  • Cue Biopharma (NASDAQ:CUE) shares moved upwards by 14.99% to $4.6. The market value of their outstanding shares is at $162.7 million.
  • Sensus Healthcare (NASDAQ:SRTS) shares moved upwards by 11.73% to $8.0. The company's market cap stands at $133.4 million. As per the press release, Q1 earnings came out yesterday.
  • LogicBio Therapeutics (NASDAQ:LOGC) stock rose 10.85% to $0.61. The market value of their outstanding shares is at $20.1 million.
  • AcelRx Pharmaceuticals (NASDAQ:ACRX) stock increased by 8.77% to $0.23. The company's market cap stands at $33.5 million.
  • ChemoCentryx (NASDAQ:CCXI) shares increased by 8.69% to $17.0. The market value of their outstanding shares is at $1.2 billion. The company's, Q1 earnings came out yesterday.

Losers

  • Endo International (NASDAQ:ENDP) shares fell 38.1% to $1.25 during Friday's pre-market session. The company's market cap stands at $293.8 million. As per the press release, Q1 earnings came out yesterday.
  • T2 Biosystems (NASDAQ:TTOO) stock fell 18.71% to $0.31. The market value of their outstanding shares is at $53.5 million. As per the news, the Q1 earnings report came out yesterday.
  • Kintara Therapeutics (NASDAQ:KTRA) shares decreased by 10.48% to $0.19. The market value of their outstanding shares is at $12.4 million.
  • Sonoma Pharmaceuticals (NASDAQ:SNOA) shares decreased by 10.32% to $3.13. The market value of their outstanding shares is at $9.6 million.
  • Monopar Therapeutics (NASDAQ:MNPR) stock declined by 9.1% to $2.0. The market value of their outstanding shares is at $25.2 million.
  • Vanda Pharmaceuticals (NASDAQ:VNDA) stock fell 8.17% to $9.0. The market value of their outstanding shares is at $508.4 million. The company's, Q1 earnings came out yesterday. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment